Sébastien Q.
- Country
- France
- Department
- Department of pneumology and physiology
Research Overview
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
- Open‑Label Multi‑Center Extension Study of Admilparant for Long‑Term Safety and Tolerability in Patients with Idiopathic or Progressive Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 183 of 249 partner sites.
Specializations
Pulmonary Fibrosis Research
This investigator specializes in treating various forms of pulmonary fibrosis, with particular focus on idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).
- Disease progression management
- Therapeutic interventions for lung function
- Acute exacerbation treatment
The research encompasses novel therapeutic approaches for maintaining and improving respiratory function in fibrotic conditions.
Interstitial Lung Disease Studies
Dedicated to advancing treatment options for interstitial lung diseases (ILD), including progressive fibrosing ILD and variants associated with systemic conditions.
- Inflammatory component management
- Progressive ILD treatment strategies
- Systemic sclerosis-related ILD
The focus includes evaluating innovative therapeutic combinations for various ILD manifestations.
Specialized Respiratory Conditions
Investigates specific respiratory conditions including pulmonary sarcoidosis and associated symptomatic manifestations such as chronic cough in fibrosing lung diseases.
- Sarcoidosis treatment evaluation
- Cough management in fibrotic conditions
- Long-term disease monitoring
The research aims to address both primary disease processes and associated respiratory symptoms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
